The CFDA pilot let go of the traditional Chinese medicine enterprise rob food formula particles

The 2016-01-31

Source: China business news

Sig pharmaceutical bulletin on January 22, the company plans to invest 650 million yuan in guangdong province puning construction of traditional Chinese medicine formula particles. Sig pharmaceutical the investment plan, when the food drug safety administration has just issued the measures for the management of traditional Chinese medicine formula particles (draft) ".

According to statistics, over the next three years, traditional Chinese medicine formula particles will remain around 30% growth, by 2016 the market overall scale is expected to exceed 10 billion yuan, to a rapid rise in 2018 to 20 billion yuan. But at present domestic only six companies on the market. Such market pattern for many large Chinese medicine enterprises call unfair, some drug companies with the support of the local food and drug administration, has been in the province to carry out the traditional Chinese medicine formula particles.

As the "draft" deadline coming on March 1, 2016, Chinese traditional medicine grain market will face a tyrannical and the new Chinese traditional medicine eat.

Monopoly to break the ice

Market analysts, if let go of the traditional Chinese medicine formula particles pilot limits, the biggest impact will be the last day of Chinese medicine has just been bought jiang pharmaceutical industry.

In October last year, jiangyin day jiang pharmaceutical 81.48% by China traditional Chinese medicine (TCM) the price of 8.346 billion yuan in cash, when more than 10.4 billion yuan of total amount of the personage inside course of study is considered valuation is far too high, and the risk of overvalued is that sooner or later the government will let go of the pilot.

, head of the Beijing minister pharmaceutical consulting Shi Lichen told the China business news reporter, food drug safety administration to the six companies the opportunity to pilot, is expected to form a set of reference for all Chinese medicine enterprises of traditional Chinese medicine formula granules production standards and quality standards, but after more than ten years in the past, the above several companies relying on the pilot identity status, focusing make a lot of money, fragmented in the unified standard, the government unveiled "draft", main purpose is to form a unified standard.

From 2002 to 2004, the agency has passed the day jiang pharmaceutical co., a pharmaceutical (by day after jiang pharmaceutical industry mergers and acquisitions), Kang Rentang (after the red sun pharmaceutical industry mergers and acquisitions), CRC san-jiu pharmaceutical co., sichuan new green pharmaceutical, nanning empower pharmaceutical six traditional Chinese medicine formula particles such as pilot factory.

Pilot monopolistic industry, let the above 6 companies benefit.

In the pilot enterprises, with the combined day jiang pharmaceutical industry the most powerful, its in the industry leading position, its market share of 50% or more. Data show that day jiang pharmaceutical industry from 2011 to 2014 the main business income is 1.247 billion yuan respectively, 1.892 billion yuan, 2.508 billion yuan and 1.892 billion yuan. Net income 293 million yuan, 418 million yuan and 546 million yuan respectively, at the end of 2014, that number had soared to 652 million yuan.

Another traditional Chinese medicine formula particles enterprises, red sun pharmaceutical bought by Kang Rentang, raised $950 million in 2014 for tianjin Kang Rentang building automation production base project "" Chinese medicine products, plans to build production of single Chinese medicine granules, a total of 2500 tons, 3000 tons of refined Chinese medicine yinpian base. According to the red sun pharmaceutical 2014 annual report, red sun pharmaceutical 2014 TCM formula granule sales income 1.22 billion yuan, up 51.69% from a year earlier.

Nanning empower is the only foreign companies in the pilot enterprises, also for many years become the Hong Kong hospital authority concentrated herbal medicine for suppliers. Few data to check the company in the mainland, only can refer to that, the company empower group in Hong Kong in 2011 to build the annual output of 2000 tons of TCM formula granule production line expansion projects, which means that nanning empower the annual output of more than 2000 tons, at least, and according to the formula granules are sold to mainland Hong Kong price is high, its annual revenue below Kang Rentang of $1.22 billion.

As for sichuan new green, the reporter understands, the company is in the pilot enterprises, the only from the medicinal herbs GAP planting base to Chinese medicine yinpian GMP production and research and development of traditional Chinese medicine formula particles, then to traditional Chinese medicine formula particles GMP production country fixed-point TCM formula granule production enterprises. With independent drug import and export rights, the sales network all over the country, products are exported to Japan, Hong Kong, China, southeast Asia, Australia, the United States, Canada, Europe and other countries and regions.

Huarun san-jiu due to capacity problem, its formula particles business stalled, and the company in early 2015, the company production capacity problem has been solved, the second phase project has started the construction of a productivity in the process of implementation, the future will continue to expand formula particles business support.

Traditional Chinese medicine granules 3. JPG

Six pilot enterprises merge the party day jiang pharmaceutical pharmaceutical, due to its high in the domestic market share, business coverage, the future will be other enterprise competition is the primary object of Chinese medicine, and several other pilot enterprises because of either the market abroad, or market share is relatively small, is affected by pilot release co., LTD.

Pilot enterprises one of the executives who declined to be named, told reporters that formula particles industry is still very small, let go of the industry is a good thing, previously entered the pilot enterprises in this field still have some voice.

Eat the cake

In fact, as early as during the pilot, part of the province of large medicine enterprises have been actively involved in traditional Chinese medicine formula particles.

Compared to pharmaceutical industry has been in hebei province for example, eat the food and drug administration approval to carry out scientific research, the sunway pharmaceutical even in recruiting for formula particles projects.

Pharmaceutical industry is the jilin province jilin ao only for traditional Chinese medicine formula particles within the trial production qualification of the enterprise. Chairman of jilin ao xiu-lin li told reporters that the company research and development of traditional Chinese medicine formula particles continues, is still trying to get the qualification for production.

Just got in anhui province in 2014, a TCM formula granule production qualification of anhui people dhi pharmaceutical co., LTD. (hereinafter referred to as the "economic man pharmaceutical") is at the start of the formula particles of scientific research work, and in early 2015 in anhui market sales preparation.

After a Yang manager, told reporters that in the coming years once the industry standard form, open market access will be the inevitable choice. Although six pilot enterprises advantage in yet, but is bound to face other drug firms market impact, then day jiang pharmaceutical value will be slashed.

In addition to the above several companies have been fighting for landing, other drug companies listed companies are active layout TCM formula granule.

On January 19, 2016, huatong medical announcement, a wholly owned subsidiary company of zhejiang JingYueTang pharmaceutical co., LTD. Has received the pharmaceutical GMP certificate about traditional Chinese medicine formula particles. As early as October 29, huatong medical already for JingYueTang pharmaceutical capital increase to 60 million yuan, with the points cut open after formulation grain market.

On January 25, 2016, and sig pharmaceutical industry plans to invest 650 million yuan in guangdong province puning construction of traditional Chinese medicine formula particles. The project total land area of 12000 square meters. Project will be a new 12 production lines, Chinese medicine extraction capacity of about 6000 tons, is expected to development and production of radix glycyrrhizae, poria cocos, angelica, radix paeoniae alba, etc varieties of traditional Chinese medicine formula particles produce about 450 species, annual production of about 2.4 billion packages. This means that a second day jiang pharmaceutical formulations particles production of competitors will be formed.

The traditional Chinese medicine formula particles project, is may carry the behavior of the pilot enterprises. And according to the reporter, many provinces before the "draft" has approved some formula particle production and sales.

It is reported, by the post industrial co., LTD. Hangzhou matsuura pharmaceutical co., LTD and Japan joint venture of zhejiang HuiSong pharmaceutical co., LTD, has been declared in zhejiang province dozens of enterprises successfully approved by the authorized to carry on the production and sales of traditional Chinese medicine formula particles, at present the company has been in the local recruitment, intentions points soup with Chinese medicine formula particles.

"Market share, means that the possibility of the object being as competition is very big also, although the pilot after let go, the amount of the market will continue to expand, but others will pilot enterprises for benchmarking, in capital investment, market development, as well as on the talent introduction and pilot enterprises to compete. So, in the future if there is a large Chinese medicine enterprises in this field, they will be on the channels of traditional Chinese medicine, hospital on terminal channels, capital and technology have a certain advantage." Shi Lichen said.